Bristol-Myers Squibb Company (Bristol-Myers Squibb or BMS), incorporated in August 1933, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare-related products. The Company has three segments: Pharmaceuticals, Nutritionals and ConvaTec. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The other two segments '€“ Nutritionals and ConvaTec '€“ comprise the Company's Health Care Group. The Nutritionals segment consists of Mead Johnson Nutritionals (Mead Johnson), primarily an infant formula and children's nutritionals business. The ConvaTec segment consists of the ostomy, wound and skin care business. On January 7, 2008, the Company completed the sale of its Medical Imaging business to Avista Capital Partners L.P. In October 2007, BMS completed the acquisition of Adnexus Therapeutics, Inc.